LIFE SCIENCES GROWTH CONTINUUM

Despite the wide diversity of products, your life sciences company proceeds through predictable phases to bring products to market. Ashton Tweed has developed a model for the components of this process called the Life Sciences Growth Continuum.

As your company advances through the continuum, your needs for human capital will expand, both in the management ranks and the business infrastructure. Ashton Tweed’s partners have the life sciences industry experience to successfully source highly skilled experts with the specific background and knowledge required to assist your company in successfully navigating each phase of your growth.

Ashton Tweed helps your life sciences company plan a human capital strategy so that the right people are in place when they are needed.

 

VITAL ROLES IN THE LIFE SCIENCES GROWTH CONTINUUM

Life Sciences Growth Continuum

  • Senior management — the right people to attract investment dollars
  • Fundraising — skilled fundraisers to shorten the investment cycle
  • R&D — innovative research personnel
  • Product development — executives adept at converting R&D into products
  • Manufacturing — professionals to get your product made
  • Regulatory — executives skilled at developing your company’s effective regulatory strategy
  • Clinical trials — executives experienced at gaining FDA approval
  • Statistical analysis — professionals skilled at interpreting results
  • Marketing and sales — business development executives with the right plan
  • Infrastructure — management of human capital, finance, and IT
 

For guidance leading your company through the growth continuum, please contact Ashton Tweed at 610-725-0290.

The FDA has approved the first MRI device specifically for use in neonatal intensive care units. https://t.co/46tSVpbNGt
Vertex reported positive clinical results for three of its cystic fibrosis triple combination treatments! https://t.co/E6uzdznI0s
Mitsubishi Tanabe to acquire NeuroDerm, a drug company focused on treatments for Parkinson's disease, for $1.1B! https://t.co/7hZ5tLbhMq
This biotech needed a CMO to lead all aspects of US & international clinical trial development of pipeline products: https://t.co/zsZBJ9MKNe
Ashton's Tip of the Week: Making introductions is a form of networking. Know two people who might be helpful to one… https://t.co/AxQpT054D5
Quest acquired 2 lab businesses in TX, establishing a national center of excellence for cancer precision diagnostics.https://t.co/YwEA7erRvR
Ex Google exec teams up w/ Mayo Clinic to develop tools to screen for a heart rhythm that kills thousands each year. https://t.co/FRnrbexS0j
#ThrowbackThursday to Gregor Johann Mendel, born this day in 1822, the founder of the modern science of genetics. https://t.co/9tXMewy9O5
A pair of Zika vaccines, given to mice before pregnancy, protected their offspring from Zika infection. https://t.co/ipcDTKUmYg
Sanofi and GSK are beginning shipments for flu season, expecting to dispatch up to 70M and 40M doses respectively. https://t.co/mJMftbGT5q
http://ashtontweed.com/resume-submission-process/